VIVO Financial Facts
Total other income (expense): -143KAVERAGE NUMBER OF COMMON SHARES OUTSTANDING - DILUTED: -84.82M
See Full Income Statement
Machinery, equipment and furniture: 45.09M
Accounts payable: 7.63M
See Full Balance Sheet
Meridian Bioscience Inc. (VIVO) Earnings
|
Expand Research on VIVO
| Next EPS Date | 12/2/26 | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | +39.6% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | +5.7% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 12/2/26 |
Q426 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 9/29/26 |
Q326 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 9/28/26 |
Q326 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 9/25/26 |
Q326 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 9/23/26 |
Q326 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 9/22/26 |
Q326 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 9/21/26 |
Q326 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 9/18/26 |
Q326 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |




